202 related articles for article (PubMed ID: 35290246)
1. Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants.
Wu WL; Chiang CY; Lai SC; Yu CY; Huang YL; Liao HC; Liao CL; Chen HW; Liu SJ
JCI Insight; 2022 Apr; 7(8):. PubMed ID: 35290246
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants.
Ko SH; Chen WY; Su SC; Lin HT; Ke FY; Liang KH; Hsu FF; Kumari M; Fu CY; Wu HC
J Biomed Sci; 2022 Dec; 29(1):108. PubMed ID: 36550570
[TBL] [Abstract][Full Text] [Related]
3. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
[TBL] [Abstract][Full Text] [Related]
4. A Novel Conserved Linear Neutralizing Epitope on the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.
Hua RH; Zhang SJ; Niu B; Ge JY; Lan T; Bu ZG
Microbiol Spectr; 2023 Aug; 11(4):e0119023. PubMed ID: 37306579
[TBL] [Abstract][Full Text] [Related]
5. Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant.
Wen K; Cai JP; Fan X; Zhang X; Luo C; Tang KM; Shuai H; Chen LL; Zhang RR; Situ J; Tsoi HW; Wang K; Chan JF; Yuan S; Yuen KY; Zhou H; To KK
Front Cell Infect Microbiol; 2023; 13():1213806. PubMed ID: 37645378
[TBL] [Abstract][Full Text] [Related]
6. Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain.
Gao X; Fan L; Zheng B; Li H; Wang J; Zhang L; Li J; Zhu F
Hum Vaccin Immunother; 2022 Nov; 18(5):2055373. PubMed ID: 35417303
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion.
Li CJ; Chao TL; Chang TY; Hsiao CC; Lu DC; Chiang YW; Lai GC; Tsai YM; Fang JT; Ieong S; Wang JT; Chang SY; Chang SC
Microbiol Spectr; 2022 Apr; 10(2):e0181421. PubMed ID: 35293796
[TBL] [Abstract][Full Text] [Related]
8. Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.
Ji Y; Zhang Q; Cheng L; Ge J; Wang R; Fang M; Mucker EM; Chen P; Ma J; Zhang R; Li C; Hammond H; Baracco L; Holbrook M; Frieman M; Zhang Z; Wang X; Hooper JW; Zhang L; Zhu Q
Front Immunol; 2022; 13():980435. PubMed ID: 36189212
[TBL] [Abstract][Full Text] [Related]
9. Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection.
Guenthoer J; Lilly M; Starr TN; Dadonaite B; Lovendahl KN; Croft JT; Stoddard CI; Chohan V; Ding S; Ruiz F; Kopp MS; Finzi A; Bloom JD; Chu HY; Lee KK; Overbaugh J
Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2220948120. PubMed ID: 37253011
[TBL] [Abstract][Full Text] [Related]
10.
Das NC; Chakraborty P; Bayry J; Mukherjee S
Front Immunol; 2021; 12():782506. PubMed ID: 35082779
[TBL] [Abstract][Full Text] [Related]
11. A novel mAb broadly neutralizes SARS-CoV-2 VOCs in vitro and in vivo, including the Omicron variants.
Kan Q; Lin X; Li T; Ke X; Jian X; Hou L; Zhang W; Wan Z; Xie Q; Shao H; Ye L; Ye J; Qin A; Zou Z; Chen Q
J Med Virol; 2023 Mar; 95(3):e28657. PubMed ID: 36912367
[TBL] [Abstract][Full Text] [Related]
12. Discordant Antigenic Properties of Soluble and Virion SARS-CoV-2 Spike Proteins.
Kumar S; Dasgupta S; Sajadi MM; Snyder GA; DeVico AL; Ray K
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543772
[TBL] [Abstract][Full Text] [Related]
13. Novel neutralizing mouse-human chimeric monoclonal antibodies against the SARS-CoV-2 receptor binding domain.
Ghorbani A; Maghsood F; Yadegari H; Bahadori T; Zarnani AH; Razavi SA; Jeddi-Tehrani M; Amiri MM; Shokri F
J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37387700
[No Abstract] [Full Text] [Related]
14. Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody.
Piepenbrink MS; Park JG; Deshpande A; Loos A; Ye C; Basu M; Sarkar S; Khalil AM; Chauvin D; Woo J; Lovalenti P; Erdmann NB; Goepfert PA; Truong VL; Bowen RA; Walter MR; Martinez-Sobrido L; Kobie JJ
PLoS Pathog; 2022 Jul; 18(7):e1010691. PubMed ID: 35862475
[TBL] [Abstract][Full Text] [Related]
15. Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo.
Wang Q; Peng L; Nie Y; Shu Y; Zhang H; Song Z; Li Y; Hu H; Li L; Wang X; Liu J; Li J; Shi Z; Deng F; Guo Y; Zhou Y; Yan B; Hu Z; Wang M
Virol Sin; 2023 Apr; 38(2):257-267. PubMed ID: 36596381
[TBL] [Abstract][Full Text] [Related]
16. A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD.
Wang X; Hu A; Chen X; Zhang Y; Yu F; Yue S; Li A; Zhang J; Pan Z; Yang Y; Lin Y; Gao L; Zhou J; Zhao J; Li F; Shi Y; Huang F; Yang X; Peng Y; Tu L; Zhang H; Zheng H; He J; Zhang H; Xu L; Huang Q; Zhu Y; Deng K; Ye L
Signal Transduct Target Ther; 2022 Apr; 7(1):114. PubMed ID: 35383141
[TBL] [Abstract][Full Text] [Related]
17. Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants.
Du W; Janssens R; Mykytyn AZ; Li W; Drabek D; van Haperen R; Chatziandreou M; Rissmann M; van der Lee J; van Dortmondt M; Martin IS; van Kuppeveld FJM; Hurdiss DL; Haagmans BL; Grosveld F; Bosch BJ
Front Immunol; 2023; 14():1111385. PubMed ID: 36895554
[TBL] [Abstract][Full Text] [Related]
18. Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.
Goo J; Jeong Y; Park YS; Yang E; Jung DI; Rho S; Park U; Sung H; Park PG; Choi JA; Seo SH; Cho NH; Lee H; Lee JM; Kim JO; Song M
Virus Res; 2020 Mar; 278():197863. PubMed ID: 31945421
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters.
Su W; Sia SF; Schmitz AJ; Bricker TL; Starr TN; Greaney AJ; Turner JS; Mohammed BM; Liu Z; Choy KT; Darling TL; Joshi A; Cheng KM; Wong AYL; Harastani HH; Nicholls JM; Whelan SPJ; Bloom JD; Yen HL; Ellebedy AH; Boon ACM
mBio; 2021 Oct; 12(5):e0239521. PubMed ID: 34517754
[TBL] [Abstract][Full Text] [Related]
20. Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein.
Wang A; Tian Y; Liu H; Ding P; Chen Y; Liang C; Du Y; Jiang D; Zhu X; Yin J; Zhang G
Emerg Microbes Infect; 2022 Dec; 11(1):2120-2131. PubMed ID: 35916768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
